A Study of Two Different Formulations of Pirtobrutinib (LOXO-305) In Healthy Participants
Status:
COMPLETED
Trial end date:
2021-12-22
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare two different formulations (mixtures) of pirtobrutinib (LOXO-305) in healthy participants. This study will compare how much of each formulation gets into the blood stream and how long it takes the body to remove it. Information about any side effects that may occur will be collected. The study will last up to 65 days.